The feud heats up as Gov. Landry unofficially calls for a special session to rein in rising prescription drug costs and take ...

Calling it a “difficult decision,” Gov. Kim Reynolds signed legislation Wednesday that’s intended to help keep rural pharmacies in business but could also lead to higher drug costs for Iowans.

A closely watched bill that aimed to regulate pharmacy benefit managers, or PBMs, failed to make it through the Senate. But ...

Like a solar flare suddenly erupting, in the last week of its session after little attention to the issue the Louisiana Legislature appears poised to enact significant and almost unprecedented ...

As the rising cost of prescription medications in the United States becomes an increasing barrier for millions of people, how ...

Giving small-molecule drugs the same 13-year exemption from price negotiation as biologics would cost the federal government billions of dollars, argue three Harvard researchers ...

Federal agencies have scheduled a series of three web-based "listening sessions" to hear from commenters about issues that might be limiting competition in the U.S. prescription drug market and ...

AbCellera Biologics' drug candidates in Phase 1 trials show promise, but financial losses and slow progress raise concerns.

More than 40 reports identify hospital rates and prescription drug prices as the main drivers of rising healthcare costs. But ...

Sanofi (NASDAQ: SNY) is one of the 11 Best Drug Stocks to Buy According to Hedge Funds. Berenberg Bank analyst Luisa Hector ...

Reintroduction of the MFN model. The Trump Administration has revived the most-favored nation (MFN) drug pricing model as a seven-year test, which would tie US drug prices to the lowest prices paid by ...